Related Experiment Video
Updated: Jul 5, 2026

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
Published on: August 31, 2014
Cerebrospinal fluid viral load and intrathecal immune activation in individuals infected with different HIV-1 genetic
Sahra Abdulle1, Lars Hagberg, Bo Svennerholm
1Department of Infectious Diseases, The Sahlgrenska Academy, Göteborg University, Göteborg, Sweden. sahra.abdulle@infect.gu.se
Background:
HIV-1 exhibits a high degree of genetic diversity and is presently divided into 3 distinct HIV-1 genetic groups designated major (M), non-M/non-O (N) and outlier (O). Group M, which currently comprises 9 subtypes (A-D, F-H, J and K), at least 34 circulating recombinant forms (CRFs) and several unique recombinant forms (URFs) is responsible for most of the HIV-1 epidemic. Most of the current knowledge of HIV-1 central nervous system (CNS) infection is based on subtype B. However, subtypes other than subtype B account for the majority of global HIV-1 infections. Therefore, we investigated whether subtypes have any influence on cerebrospinal fluid (CSF) markers of HIV-1 CNS infection.
Methodology/Principal Findings:
CSF HIV-1 RNA, CSF neopterin and CSF white blood cell (WBC) count were measured in patients infected with different HIV-1 subtypes. Using multivariate regression analysis, no differences in the CSF WBC count, neopterin and viral load were found between various HIV-1 subtypes.
Conclusions:
We did not find any subtype-dependent differences in the markers evaluated in this study.
Insights
HIV subtypes do not affect central nervous system (CNS) infection markers. This study found no differences in cerebrospinal fluid (CSF) viral load, neopterin, or white blood cell counts among patients infected with various HIV-1 subtypes.
Area of Science:
- Neurovirology
- Immunology
- Genetics
Background:
- Human Immunodeficiency Virus type 1 (HIV-1) has significant genetic diversity, grouped into M, N, and O.
- Group M, responsible for the global epidemic, includes multiple subtypes and recombinant forms.
- Current understanding of HIV-1 central nervous system (CNS) infection primarily relies on subtype B, despite other subtypes being more prevalent globally.
Purpose of the Study:
- To investigate the influence of different HIV-1 subtypes on cerebrospinal fluid (CSF) markers of CNS infection.
- To determine if HIV-1 genetic diversity impacts neurological disease markers.
Main Methods:
- Measurement of CSF HIV-1 RNA, neopterin, and white blood cell (WBC) counts in patients with diverse HIV-1 subtypes.
- Application of multivariate regression analysis to compare marker levels across subtypes.
Main Results:
- No statistically significant differences were observed in CSF WBC count among different HIV-1 subtypes.
- CSF neopterin levels did not vary significantly based on the infecting HIV-1 subtype.
- Cerebrospinal fluid HIV-1 viral load showed no subtype-dependent variations.
Conclusions:
- The study found no evidence of subtype-dependent differences in the evaluated CSF markers of HIV-1 CNS infection.
- These findings suggest that HIV-1 genetic subtypes may not significantly alter the inflammatory or viral markers within the CNS.
Related Concept Videos
Cryptococcal Meningitis
Encephalitis ll: Pathophysiology
Viral Meningitis
